Physician profile
Thomas Yetter
NPI 1962105783
$1,036.52
in general payments reported to CMS, 2019-2025
9 companies · $899 in 2025
The $899 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $40.34 · 2024: $97.32 · 2025: $899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $302.28 | 2025 | Everest Spinal System, Mako, Pangea |
| Depuy Synthes Sales INC. | $274.57 | 2025 | Na |
| Medinc of Texas | $173.34 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $134.55 | 2025 | G7 |
| Vertex Pharmaceuticals Incorporated | $78.00 | 2024-2025 | |
| Mission Medical Distribution, LLC | $22.20 | 2025 | |
| Bioventus LLC | $20.79 | 2024 | Exogen Ultrasound Bone Healing System |
| Ethicon US, LLC | $16.09 | 2024 | Ethicon, Stratafix, Vistaseal |
| Astrazeneca Pharmaceuticals LP | $14.70 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Yetter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.